Agenda


Sunday, February 13, 2022

10:00 a.m. – 7:00 p.m.

COVID-19 Rapid Testing

2:00 p.m. – 7:00 p.m.

Registration

Monday, February 14, 2022

9:00 a.m. – 9:00 p.m.

Registration

9:00 a.m. – 10:30 a.m.

Government Affairs – State/Federal (members only)

11:00 a.m. – 12:00 p.m.

Policy Working Group (members only)

1:00 p.m. – 5:00 p.m.

AAM Board of Directors Meeting
(board members and invited guests only)

4:30 p.m. – 6:00 p.m.

Access! 2022 Business Exposition Meet & Greet
Come meet our exhibitors and make new connections. Whether you’re looking to advance your business or gain insights from our vendors, there will be opportunities to strike up that pivotal conversation at the Access! 2022 Business Exposition.

6:00 p.m. – 9:00 p.m.

Welcome Reception
Join us for an evening of beverages and hearty hors d’oeuvres as we reconnect in person for the first time in two years in sunny Orlando, Florida.


Tuesday, February 15, 2022

7:00 a.m. – 6:00 p.m.

Registration

7:00 a.m. – 8:00 a.m.

Networking Breakfast

7:30 a.m. – 4:30 p.m.

COVID-19 Rapid Testing

8:00 a.m. – 8:45 a.m.

Welcome to Access! 2022
AAM CEO Dan Leonard speaks on the state of the industry and the association and a look forward to the year ahead. The work of AAM is all about patient access and Dan is joined on the podium by two Americans whose health and lives have been bettered by access to generic and biosimilar medicines.

Dan Leonard
President & CEO, AAM

Voices of Access
AAM’s Voices of Access report features patients across the country speaking about the importance of generic and biosimilar medicines. This annual publication shares the impact accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives. Listen as generic medicines patient, Richard Lichty, and biosimilars medicines patient, Akaimi Davis, share their stories.

Champions of Access Award Presentation
The “Champions of Access” award recognizes AMCP for its passionate and tireless advocacy to advance the mission of improving patient health by ensuring access to high-quality, cost-effective medications and other therapies. In particular, AMCP’s Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) is critical in bringing stakeholders together to provide unbiased scientific information on the effectiveness and safety of marketed biologics, including biosimilars.

2022 Champions of Access Allies Award

Academy of Managed Care Pharmacy
Susan Cantrell, MHL, RPh, CAE
Chief Executive Officer, AMCP

8:45 a.m. – 9:05 a.m.

CMMI Keynote Address

Purva Rawal, PhD
Chief Strategy Officer, CMS Innovation Center at Centers for Medicare & Medicaid Services

9:05 a.m. – 9:40 a.m.

Networking Break

9:40 a.m. – 10:00 a.m.

CDER Keynote Address
Jacqueline Corrigan-Curay, JD, M.D.

Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER), FDA

10:00 a.m. – 11:15 a.m.

Leveraging Biosimilar Competition for Success 
U.S. biosimilars are gaining market share for manufacturers while delivering access and savings for patients and payers. In 2020 alone, biosimilar competition provided nearly $8 billion in savings for America’s patients. With more than 30 FDA-approved products and dozens more on deck, biosimilars are becoming an integral part of the pharmaceutical landscape. This session will look at how various stakeholders leverage biosimilar competition today, and the threats and opportunities on the horizon.

Moderator: Christine Simmon
Executive Vice President, Policy and Strategic Alliances, AAM
Executive Director, Biosimilars Council

Steven Allison, PharmD
Vice President of Pharmacy, AdventHealth Corporate

Martin Ares 
Vice President, Biosimilars and Specialty, Sandoz

Bret Jackson
President, Economic Alliance for Michigan

Steve Miller, M.D.
Chief Clinical Officer, Cigna

11:15 a.m. – 12:30 p.m.

WiHP Healthcare Leadership Luncheon – (open to all attendees)

Learn from and network with industry and health care’s most influential female executives. Attendees will hear firsthand from accomplished executives who have leapt over barriers and created their success. These leading women will share stories and lessons learned from their climb to the top.

Moderator: Frances Zipp
President & CEO, Lachman Consultants

Susan Cantrell, MHL, RPh, CAE 
Chief Executive Officer, AMCP

Elizabeth Goodman, JD, MSW, DrPH
Executive Vice President of Government Affairs and Innovation, AHIP

Keren Haruvi
President of Sandoz US and Head of North America, Sandoz Inc.

12:30 p.m. – 1:30 p.m.

The Generic Pharmaceutical Supply Chain: Two Years Into the Pandemic
Almost two years after the WHO declared COVID-19 a global pandemic, the generic and biosimilar supply chains continue to demonstrate resilience, ensuring America’s patients can access the medicines they need, when they need them. And despite stresses, including unprecedent demand for certain products, vial shortages stemming from the global vaccine roll-out and shipment price increases and delays, companies have been able to leverage increased stockpiles and creative solutions to address supply chain disruptions. This panel of supply chain experts and industry leaders will discuss what has worked and why and what needs to be done, both from the industry perspective and from the U.S. government perspective, to further enhance America’s supply chain resilience.

Moderator: Jonathan Kimball
Vice President, Trade, International Affairs and Strategic Initiatives, AAM

Hem Pandya
Senior Vice President, Head of Generic Product Division, Mayne Pharma

Anthony Sardella
Senior Research Advisor, Center for Analytics and Business Insights, Washington University

Alok Sonig
CEO, US Generics, Global Head Generics R&D & Biosimilars, Lupin Inc.

1:30 p.m. – 2:30 p.m.

Re-Designing Healthcare: Transparency, Affordability and Emergency Preparedness
Marty Makary, M.D., MPH

New York Times Bestselling Author & Johns Hopkins Physician

2:30 p.m. – 6:00 p.m.

Access! 2022 Business Exposition 

2:30 p.m. – 4:30 p.m.

AAM All Access Podcast (open session) 

2:30 p.m. – 3:30 p.m.

Biosimilars Council (members only)

3:30 p.m. – 4:30 p.m.

Communication Task Force (members only)

3:30 p.m. – 4:30 p.m.

Law Committee (members only)

6:00 p.m. – 7:00 p.m.

Access! 2022 Business Exposition Dinner Reception

7:00 p.m. – 10:00 p.m.

Dinner and Entertainment
Enjoy an evening at Illume Restaurant. This rooftop restaurant serves contemporary cuisine and creative cocktails in a social setting. You’ll enjoy an incredible vantage point for the fireworks displays from nearby parks.


Wednesday, Feburary 16, 2022

7:30 a.m. – 1:00 p.m.

COVID-19 Rapid Testing

7:30 a.m. – 8:30 a.m.

Networking Breakfast 

8:30 a.m. – 8:35 a.m.

Welcome to Day 2 Remarks
Dan Leonard
President and CEO, AAM

8:35 a.m. – 9:00 a.m.

AAM Chair’s Address
Alok Sonig

CEO, US Generics, Global Head Generics R&D & Biosimilars, Lupin Inc.

9:00 a.m. – 10:30 a.m.

CEOs Unplugged
With rising policy, commercial and supply chain threats to the generics and biosimilars industry, its leaders will speak to how the industry is rising to address the unprecedented challenges.

Moderator: Dan Leonard
President and CEO, AAM

Sven Dethlefs, PhD
Executive Vice President, North America Commercial, Teva

Vinita Gupta
CEO, Lupin Limited

Chirag Patel
President and Co-Chief Executive Officer, Amneal Pharmaceuticals

Richard Saynor
CEO, Sandoz

10:30 a.m. – 10:40 a.m.

Lifetime Achievement Award
The Lifetime Achievement Award is the highest honor bestowed by the Association for Accessible Medicines. It is presented to an individual whose years of devoted service, professional integrity and strategic leadership exemplify the very best in our industry. 

Joe Renner
Chairman, Zydus Pharmaceuticals USA, Inc.

10:40 a.m. – 11:00 a.m.

Networking Break 

11:00 a.m. – Noon

Global and U.S. Generics and Biosimilars: Trends, Issues and Outlook
Join industry expert Doug Long, MBA, as he explores the continuing impact of COVID-19 on the U.S. pharmaceutical market and generics and biosimilars specifically. Doug will explore reduced diagnosis visits, shifts in sites of care, acute vs. chronic prescriptions, specialty vs. traditional prescriptions and the lack of a 2020-2021 flu season, among other issues. Doug will also look ahead to the rest of 2022 and beyond.

Doug Long
Vice President, Industry Relations, IQVIA

Noon – 1:30 p.m.

Sustainability of the U.S. Generic Model
Where is our industry headed, and how are stakeholders innovating around challenges in the system? Charles-Andre Brouwers will discuss the findings of Boston Consulting Group’s year-long project to identify the pain points and opportunities that AAM members will face in the short and medium term. Come hear how the industry and its association are being positioned to address the most critical issues affecting the financial sustainability of the generics and biosimilars industry. Then hear a distinguished group of experts talk about how they see opportunities to address challenges through business and policy innovation.

Charles-André Brouwers
Senior Partner and Managing Director, Boston Consulting Group

John Brooks, JD
Partner, South Capitol

Alex Oshmyansky, M.D., PhD
Founder and CEO of Mark Cuban Cost Plus Drug Company

Wayne Russell, RPh, PharmD, FASHP
Vice President, Pharmacy, Premier Inc.

1:30 p.m. – 1:35 p.m.

Closing Remarks

1:35 p.m. – 2:35 p.m.

Farewell Luncheon
Saying goodbye is never easy, but it’s even harder to do in a remote world. Join your colleagues one last time as we say our goodbyes until next year’s Access! conference.